NMRA
Neumora Therapeutics, Inc. · Healthcare
Director Matthew K Fust sold $371K of Neumora Therapeutics, Inc.
Sold$370,962
$17.03Price
21,788Shares
−52%Stake
What NMRA did after the filing
- The stock from Fri, Oct 18 close, $16.49
- −40.6%
- S&P 500, same days
- +3.3%
Measured over 30 trading days, to the Dec 2 close.
Traded Thu, Oct 17. Filed Fri, Oct 18, 2:25 PM ET, during the session. Returns use the Oct 18 close and the Dec 2 close. Not investment advice.